Radiopharmaceuticals in Nuclear Medicine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY

2.1 Summary about Radiopharmaceuticals in Nuclear Medicine Industry

2.2 Radiopharmaceuticals in Nuclear Medicine Market Trends

2.2.1 Radiopharmaceuticals in Nuclear Medicine Production & Consumption Trends

2.2.2 Radiopharmaceuticals in Nuclear Medicine Demand Structure Trends

2.3 Radiopharmaceuticals in Nuclear Medicine Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Diagnostic Radiopharmaceuticals

4.2.2 Therapy Radiopharmaceuticals

4.2.3 Enriched Stable Isotopes

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Diagnostic Application

4.3.2 Therapeutic Application

4.3.3 Research

4.3.4 Pharmaceutical

4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Diagnostic Radiopharmaceuticals

5.2.2 Therapy Radiopharmaceuticals

5.2.3 Enriched Stable Isotopes

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Diagnostic Application

5.3.2 Therapeutic Application

5.3.3 Research

5.3.4 Pharmaceutical

5.3.5 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Diagnostic Radiopharmaceuticals

6.2.2 Therapy Radiopharmaceuticals

6.2.3 Enriched Stable Isotopes

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Diagnostic Application

6.3.2 Therapeutic Application

6.3.3 Research

6.3.4 Pharmaceutical

6.3.5 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Diagnostic Radiopharmaceuticals

7.2.2 Therapy Radiopharmaceuticals

7.2.3 Enriched Stable Isotopes

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Diagnostic Application

7.3.2 Therapeutic Application

7.3.3 Research

7.3.4 Pharmaceutical

7.3.5 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Diagnostic Radiopharmaceuticals

8.2.2 Therapy Radiopharmaceuticals

8.2.3 Enriched Stable Isotopes

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Diagnostic Application

8.3.2 Therapeutic Application

8.3.3 Research

8.3.4 Pharmaceutical

8.3.5 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Diagnostic Radiopharmaceuticals

9.2.2 Therapy Radiopharmaceuticals

9.2.3 Enriched Stable Isotopes

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Diagnostic Application

9.3.2 Therapeutic Application

9.3.3 Research

9.3.4 Pharmaceutical

9.3.5 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Bracco Imaging S.P.A.

10.1.2 Cambridge Isotope Laboratories, Inc.

10.1.3 Cardinal Health, Inc.

10.1.4 Covidien, Plc

10.1.5 Eczacibasi-Monrol

10.1.6 Fujifilm Holdings Corporation

10.1.7 GE Healthcare (Subsidiary Of General Electric Company)

10.1.8 IBA Group

10.1.9 Isotec, Inc. (Sigma-Aldrich)

10.1.10 Lantheus Medical Imaging, Inc.

10.1.11 Nordion, Inc.

10.1.12 Ntp Radioisotopes (Pty), Ltd.

10.1.13 Siemens Healthcare (Subsidiary Of Siemens AG)

10.1.14 Taiyo Nippon Sanso Corporation

10.1.15 Urenco Limited

10.1.16 Rotem Industries, Ltd., Inc.

10.1.17 Australian Nuclear Association And Technology Organization (ANSTO)

10.1.18 Board of Radiation And Isotope Technology (BRIT)

10.1.19 Institute of Atomic Energy Polatom Radioisotope Centre

10.1.20 Institute of Isotopes Co., Ltd.

10.1.21 Institute Of Radioelement (IRE)

10.2 Radiopharmaceuticals in Nuclear Medicine Sales Date of Major Players (2017-2020e)

10.2.1 Bracco Imaging S.P.A.

10.2.2 Cambridge Isotope Laboratories, Inc.

10.2.3 Cardinal Health, Inc.

10.2.4 Covidien, Plc

10.2.5 Eczacibasi-Monrol

10.2.6 Fujifilm Holdings Corporation

10.2.7 GE Healthcare (Subsidiary Of General Electric Company)

10.2.8 IBA Group

10.2.9 Isotec, Inc. (Sigma-Aldrich)

10.2.10 Lantheus Medical Imaging, Inc.

10.2.11 Nordion, Inc.

10.2.12 Ntp Radioisotopes (Pty), Ltd.

10.2.13 Siemens Healthcare (Subsidiary Of Siemens AG)

10.2.14 Taiyo Nippon Sanso Corporation

10.2.15 Urenco Limited

10.2.16 Rotem Industries, Ltd., Inc.

10.2.17 Australian Nuclear Association And Technology Organization (ANSTO)

10.2.18 Board of Radiation And Isotope Technology (BRIT)

10.2.19 Institute of Atomic Energy Polatom Radioisotope Centre

10.2.20 Institute of Isotopes Co., Ltd.

10.2.21 Institute Of Radioelement (IRE)

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Radiopharmaceuticals in Nuclear Medicine Product Type Overview

Table Radiopharmaceuticals in Nuclear Medicine Product Type Market Share List

Table Radiopharmaceuticals in Nuclear Medicine Product Type of Major Players

Table Brief Introduction of Bracco Imaging S.P.A.

Table Brief Introduction of Cambridge Isotope Laboratories, Inc.

Table Brief Introduction of Cardinal Health, Inc.

Table Brief Introduction of Covidien, Plc

Table Brief Introduction of Eczacibasi-Monrol

Table Brief Introduction of Fujifilm Holdings Corporation

Table Brief Introduction of GE Healthcare (Subsidiary Of General Electric Company)

Table Brief Introduction of IBA Group

Table Brief Introduction of Isotec, Inc. (Sigma-Aldrich)

Table Brief Introduction of Lantheus Medical Imaging, Inc.

Table Brief Introduction of Nordion, Inc.

Table Brief Introduction of Ntp Radioisotopes (Pty), Ltd.

Table Brief Introduction of Siemens Healthcare (Subsidiary Of Siemens AG)

Table Brief Introduction of Taiyo Nippon Sanso Corporation

Table Brief Introduction of Urenco Limited

Table Brief Introduction of Rotem Industries, Ltd., Inc.

Table Brief Introduction of Australian Nuclear Association And Technology Organization (ANSTO)

Table Brief Introduction of Board of Radiation And Isotope Technology (BRIT)

Table Brief Introduction of Institute of Atomic Energy Polatom Radioisotope Centre

Table Brief Introduction of Institute of Isotopes Co., Ltd.

Table Brief Introduction of Institute Of Radioelement (IRE)

Table Products & Services of Bracco Imaging S.P.A.

Table Products & Services of Cambridge Isotope Laboratories, Inc.

Table Products & Services of Cardinal Health, Inc.

Table Products & Services of Covidien, Plc

Table Products & Services of Eczacibasi-Monrol

Table Products & Services of Fujifilm Holdings Corporation

Table Products & Services of GE Healthcare (Subsidiary Of General Electric Company)

Table Products & Services of IBA Group

Table Products & Services of Isotec, Inc. (Sigma-Aldrich)

Table Products & Services of Lantheus Medical Imaging, Inc.

Table Products & Services of Nordion, Inc.

Table Products & Services of Ntp Radioisotopes (Pty), Ltd.

Table Products & Services of Siemens Healthcare (Subsidiary Of Siemens AG)

Table Products & Services of Taiyo Nippon Sanso Corporation

Table Products & Services of Urenco Limited

Table Products & Services of Rotem Industries, Ltd., Inc.

Table Products & Services of Australian Nuclear Association And Technology Organization (ANSTO)

Table Products & Services of Board of Radiation And Isotope Technology (BRIT)

Table Products & Services of Institute of Atomic Energy Polatom Radioisotope Centre

Table Products & Services of Institute of Isotopes Co., Ltd.

Table Products & Services of Institute Of Radioelement (IRE)

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) by Region 2021f-2026f

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast (Million USD) Share by Demand 2021f-2026f